U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C29H41NO4.ClH
Molecular Weight 504.101
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUPRENORPHINE HYDROCHLORIDE

SMILES

Cl.[H][C@@]12OC3=C4C(C[C@H]5N(CC6CC6)CC[C@@]14[C@@]57CC[C@@]2(OC)[C@]([H])(C7)[C@](C)(O)C(C)(C)C)=CC=C3O

InChI

InChIKey=UAIXRPCCYXNJMQ-RZIPZOSSSA-N
InChI=1S/C29H41NO4.ClH/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28;/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3;1H/t20-,21-,24-,26+,27-,28+,29-;/m1./s1

HIDE SMILES / InChI
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C29H41NO4
Molecular Weight 467.6401
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:14:12 UTC 2023
Edited
by admin
on Fri Dec 15 15:14:12 UTC 2023
Record UNII
56W8MW3EN1
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUPRENORPHINE HYDROCHLORIDE
EP   JAN   MART.   MI   ORANGE BOOK   USAN   USP   VANDF   WHO-DD  
USAN  
Official Name English
BUNAVAIL COMPONENT BUPRENORPHINE HYDROCHLORIDE
Brand Name English
CL-112302
Code English
SUBOXONE COMPONENT BUPRENORPHINE HYDROCHLORIDE
Common Name English
CL 112,302
Code English
BUPRENORPHINE HYDROCHLORIDE COMPONENT OF SUBOXONE
Common Name English
RX-6029-M HCL
Code English
BELBUCA
Brand Name English
NOPAN
Brand Name English
FINIBRON
Brand Name English
LEPETAN
Common Name English
BUPREX
Common Name English
VETERGESIC
Common Name English
BUPRENORPHINE HYDROCHLORIDE [USAN]
Common Name English
BUPRENORPHINE HYDROCHLORIDE [JAN]
Common Name English
BUPRENORPHINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
BUPREDERM
Common Name English
6,14-ETHENOMORPHINAN-7-METHANOL, 17-(CYCLOPROPYLMETHYL)-.ALPHA.-(1,1-DIMETHYLETHYL)-4,5-EPOXY-18,19-DIHYDRO-3-HYDROXY-6-METHOXY-.ALPHA.-METHYL-, HYDROCHLORIDE, (5.ALPHA.,7.ALPHA.(S))-
Common Name English
ANORFIN
Brand Name English
NIH-8805
Code English
RX 6029-M HCL
Code English
BUPRENORPHINE HYDROCHLORIDE [EP MONOGRAPH]
Common Name English
BUPRENORPHINE HYDROCHLORIDE COMPONENT OF BUNAVAIL
Brand Name English
BUPRENORPHINE HYDROCHLORIDE [MART.]
Common Name English
BUPRENORPHINE HYDROCHLORIDE [USP-RS]
Common Name English
BUPRENORPHINE HYDROCHLORIDE [USP IMPURITY]
Common Name English
BUPRENEX
Brand Name English
UM 952
Code English
BUPRENORPHINE HYDROCHLORIDE CIII
USP-RS  
Common Name English
Buprenorphine hydrochloride [WHO-DD]
Common Name English
SCH-028444
Code English
BUPRENORPHINE HYDROCHLORIDE [MI]
Common Name English
SUBUTEX
Brand Name English
BUPRENORPHINE HYDROCHLORIDE [VANDF]
Common Name English
BUPRENORPHINE HCL
Common Name English
NIH 8805
Code English
BUPRENORPHINE HYDROCHLORIDE COMPONENT OF CASSIPA
Brand Name English
BUPRENORPHINE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
21-Cyclopropyl-7α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine hydrochloride
Common Name English
BUPRENORPHINE HYDROCHLORIDE [EP IMPURITY]
Common Name English
M-6029
Code English
Classification Tree Code System Code
NCI_THESAURUS C67413
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
FDA ORPHAN DRUG 75293
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
NCI_THESAURUS C1506
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
Code System Code Type Description
EPA CompTox
DTXSID2048905
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
NCI_THESAURUS
C47424
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
DRUG BANK
DBSALT000019
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
CAS
53152-21-9
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
PUBCHEM
3033050
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
RXCUI
203841
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY RxNorm
MERCK INDEX
m2771
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY Merck Index
CHEBI
652822
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
RS_ITEM_NUM
1078700
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
DAILYMED
56W8MW3EN1
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
EVMPD
SUB13133MIG
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
SMS_ID
100000092032
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
ECHA (EC/EINECS)
258-396-8
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
FDA UNII
56W8MW3EN1
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
ChEMBL
CHEMBL511142
Created by admin on Fri Dec 15 15:14:12 UTC 2023 , Edited by admin on Fri Dec 15 15:14:12 UTC 2023
PRIMARY
Related Record Type Details
Structure of BUPRENORPHINE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of N-(3-BUTENYL)NORBUPRENORPHINE
IMPURITY -> PARENT
Structure of NORBUPRENORPHINE
IMPURITY -> PARENT
Related Record Type Details
Structure of BUPRENORPHINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966